Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2012104.pdf
Reference28 articles.
1. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154: 22–30
2. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2006) Does a negative screening colonoscopy ever need to be repeated? Gut 55: 1145–1150
3. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007) Case-control study supports extension of surveillance interval after colonoscopicpolypectomy to at least 5 yr. Am J Gastroenterol 102: 1739–1744
4. Brenner H, Haug U, Hundt S (2010a) Inter-test agreement and quantitative cross-validation of immunochromatographicalfecal occult blood tests. Int J Cancer 127: 1643–1649
5. Brenner H, Haug U, Hundt S (2010b) Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 105: 2457–2464
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer;Journal of Gastroenterology;2024-06-05
2. Progress in the field of noninvasive diagnostics for colorectal cancer: a systematic review for the accuracy of blood-based biomarkers for detection of advanced pre-cancerous lesions;Expert Review of Molecular Diagnostics;2023-12-02
3. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden;Clinical Colorectal Cancer;2023-06
4. Novel biomarkers for neoplastic progression from ulcerative colitis to colorectal cancer: a systems biology approach;Scientific Reports;2023-02-28
5. Validation of a genotype-based algorithm that identifies individuals with low, intermediate, and high serum CA19-9 levels in cancer-free individuals and in patients with colorectal cancer;Journal of Gastrointestinal Oncology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3